Burstable Health Team
Health In-Focus
@burstable
Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
2243 articles
Articles
Oncotelic's Joint Venture Identifies Biomarker Predicting Tumor Sensitivity to Intravenous Everolimus Formulation
Oncotelic Therapeutics, Inc. announced that its joint venture Sapu Nano has identified a molecular signature predicting tumor sensitivity to Sapu003, the company's intravenous Deciparticle formulation of everolimus. This biomarker framework, based on analysis of more than 9,000 tumor samples across 20 cancer types, represen...
December 4, 2025Read more
VolitionRx's Biomarker Selected for French Sepsis Detection Initiative
VolitionRx Ltd. announced that its Nu.Q NETs H3.1 assay has been selected as the exclusive biomarker for "DETECSEPS," a French government-funded initiative evaluating early sepsis detection methods. The program, part of the France 2030 plan, is led by the IHU SEPSIS and supported by a €6.3 million grant aimed at transformin...
December 4, 2025Read more
AdipoLABs Expands in Asia-Pacific with Malaysian Office and University Partnership
AdipoLABs Co., Ltd., Red & Blue Co., Ltd. from Korea, and their Malaysian subsidiary AdipoLABs Healthcare (M) Sdn Bhd have officially opened a new regional office for Asia-Pacific in Malaysia, marking a strategic expansion to strengthen leadership in non-invasive healthcare and build a robust MedTech ecosystem across ASEAN....
December 4, 2025Read more
Targeting DNA Repair Pathways Could Expand Cancer Immunotherapy Effectiveness
A newly published study indicates that cancer immunotherapy could be enhanced by targeting the pathways through which tumor cells repair DNA damage. The research suggests that disrupting these DNA damage response (DDR) mechanisms could make immunotherapy treatments effective for a broader range of patients than currently be...
December 4, 2025Read more
Rare Disease Treatments Gain Momentum Amid Growing Healthcare Challenges
The National Institutes of Health estimates that more than 30 million people nationwide are living with a rare disease, creating a rapidly intensifying challenge for the U.S. healthcare system as populations age. Most of these conditions have no FDA-approved therapies, leaving older adults particularly vulnerable since age-...
December 4, 2025Read more
Gold Prices Reach New High Amid Dollar Weakness and Fed Rate Cut Expectations
The price of gold surged to a new high at the start of this week, bolstered by a weakening dollar and increasing expectations of rate cuts by the Federal Reserve. The precious metal's price hit $4,241.27 an ounce, its highest level since October. Gold futures for February also rose to $4,274.80 an ounce. This development oc...
December 4, 2025Read more
Smart Patch Monitoring System Achieves 100% Accuracy in Pilot Study, Aiming to Prevent Medication Overdoses
A pilot study conducted by Vaaji in collaboration with the Penn Artificial Intelligence and Technology Collaboratory at the University of Pennsylvania has demonstrated 100% technical accuracy in monitoring transdermal patch status. The study, part of the AI/Tech + Aging Collective funded by the National Institute on Aging, ...
December 4, 2025Read more
GDCompt to Showcase Advanced Industrial Automation Solutions at AUTOMATE 2026 in Chicago
Guangdong Computer Intelligent Display Co., Ltd. will present its newest intelligent display terminals, industrial computers, and embedded systems for automation at the AUTOMATE Exhibition in Chicago from June 22 to 25, 2026. The exhibition, held at McCormick Place, represents one of North America's most significant events ...
December 4, 2025Read more
AdvantaPure Achieves Full USP 665 Compliance Ahead of 2026 Deadline for Pharmaceutical Products
AdvantaPure, a division of NewAge Industries, Inc., has announced full compliance with the United States Pharmacopeia (USP) 665 guideline for reporting extractables and leachables data in its plastic products. The company achieved this compliance well ahead of the May 1, 2026, deadline mandated for the high-purity market, w...
December 4, 2025Read more
SouthernMED Pediatrics Acquires Tri-County Pediatrics to Expand Healthcare Access in Northern South Carolina
SouthernMED Pediatrics has acquired Tri-County Pediatrics, expanding pediatric healthcare access in northern South Carolina's Tri-County region effective December 3, 2025. The acquisition integrates two established offices in Rock Hill and York into SouthernMED's growing statewide network, strengthening care availability in...
December 4, 2025Read more
MelGeek Centauri Series Merges Gaming Performance with Enthusiast Customization Through Advanced Magnetic Technology
The MelGeek Centauri series represents a significant development in the keyboard market by attempting to bridge the traditional divide between gaming-focused peripherals and enthusiast custom keyboards. As magnetic Hall Effect keyboards evolve from specialized gaming tools into versatile lifestyle products, users increasing...
December 4, 2025Read more
South Fork Instruments Launches Kemtrak UV Spectra Process Analyzer for Real-Time Bioprocessing Monitoring
The Kemtrak UV Spectra Process Analyzer from South Fork Instruments represents a significant advancement in real-time process monitoring technology for bioprocessing applications. This multi-wavelength deep-UV photometer is specifically designed for continuous absorbance measurement of proteins, peptides, polypeptides, mRNA...
December 4, 2025Read more
Intravenous Everolimus Formulation Shows Reduced Gastrointestinal Exposure in New Pharmacokinetic Data
New pharmacokinetic data from Oncotelic Therapeutics, Inc. reveals that its intravenous Deciparticle formulation of everolimus, designated Sapu003, significantly reduces gastrointestinal drug accumulation when compared to oral administration of the same medication. The findings demonstrate that oral dosing results in extrem...
December 3, 2025Read more
Soligenix's HyBryte Development Highlights Dual Challenge of Rare Disease Treatment and Policy Support
The growing burden of rare diseases affecting more than 30 million Americans has created an urgent need for new therapies, placing companies like Soligenix Inc. at the forefront of both medical innovation and national health policy discussions. A recent editorial titled "Chronic Rare Diseases in an Aging America: Why HyBryt...
December 3, 2025Read more
Nature Review Highlights Cardiovascular Crisis in Dialysis Patients, Sigyn's CardioDialysis Offers Non-Pharmacological Approach
A recent review article in Nature reinforces the urgent need to address cardiovascular disease in end-stage renal disease patients, reporting that ESRD dialysis patients face up to a 20-fold greater risk of death from cardiovascular disease compared to the general population. The article, accessible at https://www.nature.co...
December 3, 2025Read more
SouthernMED Pediatrics Expands Services in North Augusta Through NiteOwl Integration
SouthernMED Pediatrics has announced the integration of NiteOwl Pediatric Urgent Care into its network, creating SouthernMED Pediatrics + NiteOwl Extended Hours in North Augusta. The practice, located at 616 Edgefield Road, Suite 180, will continue providing after-hours pediatric care through December before expanding its s...
December 3, 2025Read more
Florida CCHR Demands Total Ban on Electroconvulsive Therapy Following International Survey Revealing Widespread Harm
The Florida chapter of the Citizens Commission on Human Rights is intensifying its call for a total ban on electroconvulsive therapy following the release of a landmark international survey documenting widespread patient harm and systematic violations of informed consent. Psychiatrists prescribe ECT for approximately 100,00...
December 3, 2025Read more
Bryan Therapeutics Warns of Counterfeit Nitric Oxide Products, Urges Consumer Caution
Bryan Therapeutics has issued a warning about counterfeit versions of its N1o1 and NO2U nitric oxide products, citing significant safety concerns for consumers. The company's CEO, Dr. Nathan S. Bryan, stated that products appearing to originate from Bryan Therapeutics but sold by unauthorized sellers may be stolen goods or ...
December 2, 2025Read more
Entrepreneurs Transform Personal Adversity into Business Success Through Resilience
Entrepreneur has published a new article examining how three women rebuilt their lives and careers after major personal disruptions, transforming loss into business advantages. The piece profiles Lindsay O'Neill-O'Keefe, Pam Gold, and Jenna Zwagil, whose experiences demonstrate resilience as a competitive edge for career re...
December 2, 2025Read more
Neurothera Labs Seeks Quantum Computing Acquisition to Revolutionize Clinical Analytics
Neurothera Labs Inc., a clinical-stage biotech company and majority-owned subsidiary of SciSparc Ltd., announced it has entered into a non-binding term sheet to acquire a 55% equity interest in a quantum computing bio data company focused on quantum-enabled clinical analytics. The acquisition would involve Neurothera issuin...
December 2, 2025Read more
HealthLynked Appoints Insurance and Benefits Experts to Board Amid Expansion Push
HealthLynked Corp. (OTCQB: HLYK) has appointed Chris G. Pulos of Marsh McLennan Agency and Jason Bishara of NSI Insurance Group to its Board of Directors. The company stated these appointments bring decades of experience in employer benefits, payer strategy, insurance and risk management to support its expansion efforts. Fo...
December 2, 2025Read more